Predicting Individual Survival After Hepatectomy for Hepatocellular Carcinoma: a Novel Nomogram from the “HCC East & West Study Group”

[1] Caldwell S(2009)The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology J Gastroenterol 44 96-101

[2] Park SH(2010)The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective Oncologist 15 5-13

[3] Venook AP(2009)Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 35-43

[4] Papandreou C(1996)Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693-699

[5] Furuse J(2013)A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group Ann Surg 257 929-37

[6] Mazzaferro V(2011)Management of hepatocellular carcinoma: an update Hepatology 53 1020-1022

[7] Llovet JM(2001)Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 421-430

[8] Miceli R(1999)Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 329-338

[9] Mazzaferro V(2004)Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 205-213

[10] Regalia E(2009)Quantitative assessment of unobserved confounding is mandatory in nonrandomized intervention studies J Clin Epidemiol 62 22-28

[1] Caldwell S(2009)The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology J Gastroenterol 44 96-101

[2] Park SH(2010)The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective Oncologist 15 5-13

[3] Venook AP(2009)Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 35-43

[4] Papandreou C(1996)Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693-699

[5] Furuse J(2013)A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group Ann Surg 257 929-37

[6] Mazzaferro V(2011)Management of hepatocellular carcinoma: an update Hepatology 53 1020-1022

[7] Llovet JM(2001)Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 421-430

[8] Miceli R(1999)Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 329-338

[9] Mazzaferro V(2004)Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 205-213

[10] Regalia E(2009)Quantitative assessment of unobserved confounding is mandatory in nonrandomized intervention studies J Clin Epidemiol 62 22-28